by Jason Wasserman MD PhD FRCPC
April 27, 2022
Anaplastic thyroid carcinoma is an uncommon and very aggressive type of thyroid gland cancer. While the tumour starts from cells normally found in the thyroid gland, it is often described as undifferentiated because the cells in the tumour look nothing like normal thyroid cells when examined under the microscope.
Anaplastic thyroid carcinoma is a fast-growing tumour that starts in the thyroid gland. As a result, people often notice a growth in the front of the neck. As the tumour grows it can put pressure on surrounding tissues such as the esophagus or trachea. This can result in difficulty breathing or swallowing food.
At present, we do not know what causes a person to develop anaplastic thyroid carcinoma.
The diagnosis is usually made after a small piece of the tumour is removed in a procedure called a biopsy. If the tumour cells have spread to lymph nodes, the diagnosis can also be made after examining a biopsy from one of the involved lymph nodes. The tissue is then sent to a pathologist who examines it under the microscope.
When examined under the microscope, anaplastic thyroid carcinoma is typically made up of very large and abnormal-looking cells. The cells may be described as epithelioid if they are round and stick together or spindled if they are longer than they are wide and spread apart. In addition, the tumour cells are often described as undifferentiated because they look nothing like the cells normally found in the thyroid gland. Areas of necrosis (cell death) and a large number of mitotic figures (tumour cells dividing to create new tumour cells) are commonly seen.
In some cases, anaplastic thyroid carcinoma arises from a more well-differentiated type of thyroid cancer such as papillary thyroid carcinoma or follicular carcinoma. If a more well-differentiated tumour is seen, it will be described in your report.
Pathologists often perform a test called immunohistochemistry before making the diagnosis of anaplastic thyroid carcinoma. The tumour cells in anaplastic thyroid carcinoma frequently stop making proteins normally found in thyroid cells. For this reason, the tumour cells may be positive or negative for common thyroid markers including thyroglobulin, TTF-1, and PAX-8. The tumour cells in anaplastic thyroid carcinoma often over-express the protein p53.
After the tumour is removed completely it will be measured. The tumour is usually measured in three dimensions but only the largest dimension is described in your report. For example, if the tumour measures 4.0 cm by 2.0 cm by 1.5 cm, your report will describe the tumour as being 4.0 cm. The size of the tumour is important for anaplastic thyroid carcinoma because it is used to determine the pathologic stage and because larger tumours are more likely to spread to other parts of the body such as lymph nodes.
Extrathyroidal extension is the spread of tumour cells out of the thyroid gland and into the surrounding tissues. Tumour cells that spread far enough out of the thyroid gland may come into contact with other organs such as muscles, the esophagus, or the trachea.
There are two types of extrathyroidal extension:
Macroscopic (gross) extrathyroidal extension is important because it increases the tumour stage (see Pathologic stage below) and is associated with a worse prognosis. Microscopic extrathyroidal extension does not change the tumour stage.
Vascular invasion (angioinvasion) means that cancer cells were seen inside a blood vessel. Blood vessels are long hollow tubes that carry blood around the body. Vascular invasion is important because it increases the risk that cancer cells will travel to another part of the body such as the lungs or bones.
Lymphatic invasion means that cancer cells were seen inside of a lymphatic vessel. Lymphatic vessels are small hollow tubes that allow the flow of a fluid called lymph from tissues to immune organs called lymph nodes. Lymphatic invasion is important because cancer cells can use lymphatic vessels to spread to other parts of the body such as lymph nodes or the lungs. If lymphatic invasion is seen, it will be called positive. If no lymphatic invasion is seen, it will be called negative.
A margin is the tissue that has to be cut by the surgeon to remove the thyroid gland from your body. A margin is considered positive when there are cancer cells at the very edge of the cut tissue. A negative margin means there were no cancer cells seen at the cut edge of the tissue.
Lymph nodes are small immune organs located throughout the body. Cancer cells can travel from the thyroid to a lymph node through lymphatic channels located in and around the tumour (see Lymphatic invasion above). The movement of cancer cells from the thyroid to a lymph node is called metastasis.
Your pathologist will carefully examine each lymph node for cancer cells. Lymph nodes that contain cancer cells are often called positive while those that do not contain any tumour cells are called negative. Most reports include the total number of lymph nodes examined and the number, if any, that contain cancer cells.
Lymph nodes from the neck are sometimes removed at the same time as the thyroid in a procedure called a neck dissection. The lymph nodes removed usually come from different areas of the neck and each area is called a level. The levels in the neck are numbered 1 through 7. Your pathology report will often describe how many lymph nodes were seen in each level sent for examination. Lymph nodes on the same side as the tumour are called ipsilateral while those on the opposite side of the tumour are called contralateral.
A group of cancer cells inside of a lymph node is called a tumour deposit. If a tumour deposit is found, your pathologist will measure the deposit and the largest tumour deposit found will be described in your report.
All lymph nodes are surrounded by a thin layer of tissue called a capsule. Cancer cells that have spread to a lymph node can break through the capsule and into the tissue surrounding the lymph node. This is called extranodal extension (ENE). Extranodal extension does not change the pathologic stage but your doctors may use this information when deciding which treatment is best for you.
The pathologic stage for anaplastic thyroid carcinoma is based on the TNM staging system, an internationally recognized system originally created by the American Joint Committee on Cancer. This system uses information about the primary tumour (T), lymph nodes (N), and distant metastatic disease (M) to determine the complete pathologic stage (pTNM). Your pathologist will examine the tissue submitted and give each part a number. In general, a higher number means more advanced disease and a worse prognosis.
Anaplastic thyroid carcinoma is given a tumour stage between 1 and 4 based on the size of the tumour and the presence of tumour cells outside of the thyroid (see Extrathyroidal extension above).
Anaplastic thyroid carcinoma is given a nodal stage of 0 or 1 based on the presence or absence of tumour cells in a lymph node and the location of the involved lymph nodes.
Anaplastic thyroid carcinoma is given a metastatic stage of 0 or 1 based on the presence of tumour cells at a distant site in the body (for example the lungs). The metastatic stage can only be determined if tissue from a distant site is sent for pathological examination. Because this tissue is rarely sent, the metastatic stage cannot be determined and is listed as MX.